153
Views
0
CrossRef citations to date
0
Altmetric
Brief Reports: Genomics

A novel mutation in the ALS2 gene in an iranian kurdish family with juvenile amyotrophic lateral sclerosis

, , ORCID Icon, , , , , , & ORCID Icon show all
Pages 148-151 | Received 02 May 2022, Accepted 04 Jul 2022, Published online: 19 Jul 2022
 

Abstract

Amyotrophic lateral sclerosis (ALS) is a rare disorder that affects both upper and lower motor neurons. Mutations in Alsin Rho Guanine Nucleotide Exchange Factor (ALS2) correlates with three similar but distinctive syndromes, including the juvenile form of ALS. An Iranian Kurdish family was involved in this study and all members were evaluated with relevant clinical guidelines. Whole exome sequencing and sanger sequencing were applied to all family members to undermine the possible genetic factors. A substitution c. 2110 C>T (p. Arg704X) identified in the ALS2 gene. Bioinformatics analysis indicated the mutation is located in the well-conserved and functional domain of the protein. This study recognized a novel mutation in the ALS2 gene in a proband with the juvenile form of ALS. To our knowledge, this is the first identified ALS2 mutation among the Iranian population.

Acknowledgments

We want to thank Semnan university of medical sciences for their collaboration.

Declaration of interest

All authors indicate there is no conflict of interest.

Additional information

Funding

This study has been approved by ethical committee of Tabriz University of Medical Sciences (IR.TBZMED.REC.1399.111). This study has been granted by Tabriz University of Sciences [Grant number: 64773].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.